Galena Biopharma (SLS)
(Delayed Data from NSDQ)
$1.43 USD
+0.01 (0.70%)
Updated May 22, 2024 03:59 PM ET
After-Market: $1.42 -0.01 (-0.70%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Brokerage Reports
Galena Biopharma, Inc. [SLS]
Reports for Purchase
Showing records 1 - 7 ( 7 total )
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
First Ovarian Cancer Data Point in Right Direction; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
2017 Results; Driving Towards Critical Programs for GPS; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
GPS Positioning for Success Across Multiple Tumor Types; Initiating at Buy, $11 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
With Primary Focus on Galinpepimut-S, NeuVax Gets a Nice Boost
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
|